Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 70 results for hysterectomy

  1. Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse (HTG539)

    Evidence-based recommendations on bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse in adults. This involves replacing weakened or stretched ligaments that support the uterus and hold the pelvic organs in place with mesh tape.

    HealthTech guidance
    Published
    4 March 2020
    View recommendations

    Sections for HTG539

  2. Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (HTG12)

    Evidence-based recommendations on magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids. This involves passing laser heat through needles inserted into the fibroid to destroy it.

    HealthTech guidance
    Published
    17 December 2003
    View recommendations

    Sections for HTG12

  3. Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids (TA832)

    Evidence-based recommendations on relugolix–estradiol–norethisterone acetate (Ryeqo) for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.

    Technology appraisal guidance
    Published
    19 October 2022
    View recommendations

    Sections for TA832

  4. Laparoscopic helium plasma coagulation for the treatment of endometriosis (HTG112)

    Evidence-based recommendations on laparoscopic helium plasma coagulation for the treatment of endometriosis. This involves a minimally invasive procedure used to vaporise endometrial deposits.

    HealthTech guidance
    Published
    24 May 2006
    View recommendations

    Sections for HTG112

  5. Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (HTG572)

    Evidence-based recommendations on transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids in adults. This involves inserting a device through the cervix into the womb to destroy the fibroid using radiofrequency energy.

    HealthTech guidance
    Published
    31 March 2021
    View recommendations

    Sections for HTG572

  6. Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids (HTG523)

    Evidence-based recommendations on ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids in adults. This involves focusing high-intensity ultrasound energy at the fibroids through the skin of the abdomen.

    HealthTech guidance
    Published
    24 July 2019
    View recommendations

    Sections for HTG523

  7. Blood transfusion (QS138)

    This quality standard covers the general principles of blood transfusion in adults, young people and children over 1 year old. It describes high-quality care in priority areas for improvement. It does not cover specific conditions that blood transfusion is used for.

    Quality standard
    Published
    15 December 2016
    View quality statements

    Sections for QS138

  8. Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain (HTG150)

    Evidence-based recommendations on laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. This involves the destruction of a small segment of ligament that carries nerve fibres within the pelvis.

    HealthTech guidance
    Published
    30 October 2007
    View recommendations

    Sections for HTG150

  9. Sacrocolpopexy using mesh to repair vaginal vault prolapse (HTG444)

    Evidence-based recommendations on sacropolpopexy using mesh to repair vaginal vault prolapse in women. This involves attaching mesh, usually from the top of the vagina to the base of the spine, to support the pelvic organs.

    HealthTech guidance
    Published
    28 June 2017
    View recommendations

    Sections for HTG444

  10. Infracoccygeal sacropexy using mesh to repair vaginal vault prolapse (HTG442)

    Evidence-based recommendations on infracoccygeal sacropexy using mesh to repair vaginal vault prolapse in women. This involves attaching mesh from the buttocks to the top of the vagina to hold the vagina in place.

    HealthTech guidance
    Published
    28 June 2017
    View recommendations

    Sections for HTG442

  11. Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after second-generation endometrial ablation for women with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial pathology?

    endometrial ablation and undergo unnecessary invasive surgery such as hysterectomy. On the other hand, women may be subjected to...

    Research recommendation
    Published
    14 November 2018

  12. Postpartum haemorrhage: What is the most effective treatment for primary postpartum haemorrhage?

    and blood product transfusion, need for further intervention, need for hysterectomy and psychological outcomes for the woman. Source...

    Research recommendation
    Published
    6 January 2023

  13. Menopause (QS143)

    This quality standard covers diagnosing and managing menopause in women, trans men and non-binary people registered female at birth, including those who have premature ovarian insufficiency (menopause before the age of 40, which can occur naturally or as a result of medical or surgical treatment). It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    9 February 2017
    View quality statements

    Sections for QS143

  14. Linzagolix for treating moderate to severe symptoms of uterine fibroids (TA996)

    Evidence-based recommendations on linzagolix (Yselty) for treating moderate to severe symptoms of fibroids in adults of reproductive age.

    Technology appraisal guidance
    Published
    14 August 2024
    View recommendations

    Sections for TA996

  15. Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer (IPG356)

    Interventional procedures, IPG355 - Issued: September 2010 --> We have moved interventional procedures guidance 356 to become HealthTech guidance 229. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance